Preliminary calculation of RBE-weighted dose distribution for cerebral radionecrosis in carbon-ion treatment planning

Journal of Radiation Research

Volumn 52, Issue 6, 2011, Pages 789-796

  Kase, Yuki ^a,f   Himukai, Takeshi ^a   Nagano, Ai ^a   Tameshige, Yuji ^b   Minohara, Shinichi ^a   Matsufuji, Naruhiro ^a   Mizoe, Junetsu ^c   Fossati, Piero ^c,d   Hasegawa, Azusa ^a   Kanai, Tatsuaki ^e  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Fukui Prefectural Hospital   (Japan)

^c Centro Nazionale Adroterapia Oncologica CNAO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e GUNMA UNIVERSITY HEAVY ION MEDICAL CENTER   (Japan)

^f SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Carbon ion radiotherapy; Cerebral radionecrosis; Microdosimetry; RBE weighted dose

Indexed keywords

BRAIN; CARBON; COMPUTERIZED TOMOGRAPHY; ION BEAMS; IONS; RADIOTHERAPY;

CARBON ION BEAMS; CARBON ION RADIOTHERAPY; CARBON IONS; CEREBRAL RADIONECROSIS; DOSE DISTRIBUTIONS; ION TREATMENT; MICRO-DOSIMETRY; RELATIVE BIOLOGICAL EFFECTIVENESS; RELATIVE BIOLOGICAL EFFECTIVENESS-WEIGHTED DOSE; TREATMENT PLANNING SYSTEMS;

MAGNETIC RESONANCE IMAGING;

EID: 82055182227     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.11044     Document Type: Article

References (21)

1. Tobias CA, Wenke RP and Benton EV (1973) Heavy-particle radiotherapy. Science 182: 474-476.
2. Tsujii H, et al (2007) Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res 48: A1-A13.
3. Demizu Y, et al (2009) Analysis of vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. Int J Radiat Oncol Biol Phys 75: 1487-1492.
4. Combs SE, et al (2010) Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Acta Oncologica 49: 1132-1140.
5. Kitagawa A, et al (2010) Review on heavy ion radiotherapy facilities and related ion sources. Rev Sci Instrum 81: 02B909.
6. Endo M, et al (1996) HIPLAN- a heavy ion treatment planning system at HIMAC. J Japan Soc Ther Radiol Oncol 8: 231-238.
7. Krämer M and Scholz M (2000) Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol 45: 3319-3330.
8. Kishimoto R, et al (2005) MR imaging of brain injury induced by carbon ion radiotherapy for head and neck tumors. Magnetic Resonance in Medical Sciences 4: 159-164.
9. Ruben JD, et al (2006) Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65: 449-508.
10. Miyawaki D, et al (2009) Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors. Int J Radiat Oncol Biol Phys 75: 378-384.
11. Mizoe J, et al (2007) Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 69: 390-396.
12. Hawkins R-B (2003) A microdosimetric-kinetic model for the effect of non-Poisson distribution of lethal lesions on the variation of RBE with LET. Radiat Res 160: 61-69.
13. Kase Y, et al (2006) Microdosimetric measurements and estimation of human cell survival for heavy-ion beams. Radiat Res 166: 629-638.
14. Inaniwa T, et al (2010) Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model. Phys Med Biol 55: 6721-6737.
15. Kanai T, et al (1999) Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 44: 201-210.
16. Steel GG (2000) Basic clinical radiobiology. Arnold (London): a member of the Hodder Headline Grroup.
17. Kase Y, et al (2011) Microdosimetric approach to NIRS-defined biological dose measurement for carbon-ion treatment beam. J Radiat Res 52: 59-68.
18. Koyama-Ito H, et al (2007) Carbon-ion therapy for ocular melanoma: planning orthogonal two-port treatment. Phys Med Biol 52: 5341-5352.
19. Hasegawa A, et al (2011) Experience of carbon ion radiotherapy for diffuse astrocytomas (WHO grade 2). Int J Radiat Oncol Biol Phys, accepted for publication.
20. Suzuki M, et al (2000) Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams. Int J Radiat Oncol Biol Phys 48: 241-250.
21. Kumar AJ, et al (2000) Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy and Chemotherapy-induced Necrosis of the Brain after Treatment. Radiology 217: 377-384.